Brian P Lee, MD MAS

Dr. Lee is a transplant hepatologist who cares for patients with advanced liver disease and those undergoing liver transplantation. He leads ACCELERATE, an NIH-funded national research consortium, and his research program focuses on improving health for patients with alcohol use, metabolic dysfunction, and liver disease through: 1) early transplant with alcohol; 2) the overlap of alcohol and metabolic liver disease; 3) public policy and advocacy; and 4) novel therapies and translational science. He is lead author of studies in The Lancet, JAMA Internal Medicine, Annals of Internal Medicine, Gastroenterology, Journal of Hepatology, and his work has featured in New York Times, Wall Street Journal, NPR, CNN, the New Yorker, and NBC Nightly News. He has led advocacy initiatives that changed national and statewide transplant and insurance policies to improve healthcare access, and his research has been incorporated into practice guidelines across North America, Europe, Latin America, and Asia. He is first author of international expert task force consensus guidelines for clinical trial design in alcohol use and liver disease. He serves as a standing Voting Member of the U.S. FDA Gastrointestinal Drugs Advisory Committee and as a Voting Member of the FDA Pharmacy Compounding Advisory Committee. He has served as an Associate Editor for Journal of Hepatology Reports, and currently serves as Associate Editor for Hepatology.